Show simple item record

dc.contributor.authorGuo, Xiaoxiao
dc.contributor.authorMalcolm, Jodie R.
dc.contributor.authorAli, Marrwa M.
dc.contributor.authorRibeiro Morais, Goreti
dc.contributor.authorShnyder, Steven D.
dc.contributor.authorLoadman, Paul M.
dc.contributor.authorPatterson, Laurence H.
dc.contributor.authorFalconer, Robert A.
dc.date.accessioned2020-05-18T09:33:30Z
dc.date.available2020-05-18T09:33:30Z
dc.date.issued2020-05
dc.identifier.citationGuo X, Malcolm JR, Ali MM et al (2020) An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitors. Analyst. Accepted for Publication.en_US
dc.identifier.urihttp://hdl.handle.net/10454/17821
dc.descriptionYesen_US
dc.description.abstractThe polysialyltransferases (polySTs) catalyse the polymerisation of polysialic acid, which plays an important role in tumour metastasis. While assays are available to assess polyST enzyme activity, there is no methodology available specifically optimised for identification and quantitative evaluation of potential polyST inhibitors. The development of an HPLC-fluorescence-based enzyme assay described within includes a comprehensive investigation of assay conditions, including evaluation of metal ion composition, enzyme, substrate and acceptor concentrations, temperature, pH, and tolerance to DMSO, followed by validation using known polyST inhibitors. Thorough analysis of each of the assay components provided a set of optimised conditions. Under these optimised conditions, the experimentally observed Ki value for CMP, a competitive polyST inhibitor, was strongly correlated with the predicted Ki value, based on the classical Cheng-Prusoff equation [average fold error (AFE) = 1.043]. These results indicate that this assay can provide medium-throughput analysis for enzyme inhibitors with high accuracy, through determining the corresponding IC50 values with substrate concentration at the KM, without the need to perform extensive kinetic studies for each compound. In conclusion, an in vitro cell-free assay for accurate assessment of polyST inhibition is described. The utility of the assay for routine identification of potential polyST inhibitors is demonstrated, allowing quantitative measurement of inhibition to be achieved, and exemplified through assessment of full competitive inhibition. Given the considerable and growing interest in the polySTs as important anti-metastatic targets in cancer drug discovery, this is a vital tool to enable preclinical identification and evaluation of novel polyST inhibitors.en_US
dc.description.sponsorshipYorkshire Cancer Research, Wellcome Trusten_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttps://doi.org/10.1039/D0AN00721Hen_US
dc.rights© The Royal Society of Chemistry 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence (https://creativecommons.org/licenses/by-nc/3.0/).en_US
dc.subjectPolysialyltransferaseen_US
dc.subjectEnzyme assayen_US
dc.subjectEnzyme inhibitoren_US
dc.subjectAssay developmenten_US
dc.titleAn efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitorsen_US
dc.status.refereedYesen_US
dc.date.Accepted2020-05-07
dc.date.application2020-05-08
dc.typeArticleen_US
dc.type.versionPublished versionen_US
refterms.dateFOA2020-05-18T09:34:10Z


Item file(s)

Thumbnail
Name:
d0an00721h.pdf
Size:
1.640Mb
Format:
PDF
Description:
To keep suppressed
Thumbnail
Name:
Falconer_et_al_Analyst.pdf
Size:
2.036Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record